Renal Cell Carcinoma Peptides Vaccine IMA901

Known as: IMA901 
A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
024620112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND In a phase 2 study in patients with metastatic renal cell carcinoma, overall survival was associated with T-cell… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2014
Review
2014
The promising option of immunotherapy for metastatic renal cell carcinoma has evolved from rather unspecific approaches to a… (More)
  • table 1
  • figure 1
Is this relevant?
2013
2013
The development of efficient immunotherapies requires strong rationalization. We have recently implemented a large analysis of… (More)
  • figure 1
Is this relevant?
2013
2013
Over the past several years, the dominant paradigm in drug development for metastatic renal cell carcinoma (mRCC) has been to… (More)
Is this relevant?
Review
2013
Review
2013
INTRODUCTION Immunotherapy has always been a promising therapeutic approach in metastatic renal cell carcinoma (mRCC) with… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2012
2012
 
Is this relevant?
2012
2012
Some cancer vaccines with a reasonable safety profile have demonstrated efficacy, but the holy grail of vaccine therapy is to… (More)
Is this relevant?
2012
2012
These are exciting times in the development of new immunotherapeutic strategies for cancer therapy. In particular, synthetic… (More)
Is this relevant?
2011
2011
TPS183 Background: IMA901 is a therapeutic vaccine composed of multiple naturally presented tumor-associated peptides (TUMAPs… (More)
Is this relevant?